These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 18610755)

  • 21. [Oral hypoglycemic agents and metformin in the treatment of type II non-insulin-dependent diabetes].
    Isnard F
    Sem Hop; 1983 Dec; 59(49):3437-8. PubMed ID: 6320423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metformin in cancer treatment and prevention.
    Morales DR; Morris AD
    Annu Rev Med; 2015; 66():17-29. PubMed ID: 25386929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Scant evidence on the effectiveness of metformin in type 2 diabetes.
    Perry TL
    BMJ; 2015 May; 350():h2650. PubMed ID: 25990090
    [No Abstract]   [Full Text] [Related]  

  • 24. Metformin reduces circulating factor VII concentrations in patients with type 2 diabetes mellitus.
    Grant PJ
    Thromb Haemost; 1998 Jul; 80(1):209-10. PubMed ID: 9684819
    [No Abstract]   [Full Text] [Related]  

  • 25. Overview of current therapeutic options in type 2 diabetes. Rationale for combining oral agents with insulin therapy.
    Buse JB
    Diabetes Care; 1999 Apr; 22 Suppl 3():C65-70. PubMed ID: 10189565
    [No Abstract]   [Full Text] [Related]  

  • 26. [Metformin and lactic acidosis--fact or fiction? A review of current data].
    Bläuer SC; Keller U
    Praxis (Bern 1994); 2003 Nov; 92(47):2008-10. PubMed ID: 14669502
    [No Abstract]   [Full Text] [Related]  

  • 27. The diabetologist/cardiologist debate: a meeting of the minds.
    Mohamed F; Aalbers J
    Cardiovasc J Afr; 2012 Mar; 23(2):115-7. PubMed ID: 22447480
    [No Abstract]   [Full Text] [Related]  

  • 28. [Impact of intensive blood glucose control with hypoglycemic sulfamides, metformin or insulin on complications of non-insulin dependent diabetes].
    André P
    Rev Epidemiol Sante Publique; 1999 Mar; 47(1):93-5. PubMed ID: 10214683
    [No Abstract]   [Full Text] [Related]  

  • 29. Metformin: a biguanide.
    Tanja JJ; Langlass TM
    Diabetes Educ; 1995; 21(6):509-10, 513-4. PubMed ID: 8549253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetes in the new General Medical Services contract: targets and adherence to metformin therapy.
    Kirby M
    Int J Clin Pract; 2005 Mar; 59(3):263-6. PubMed ID: 15857318
    [No Abstract]   [Full Text] [Related]  

  • 31. WITHDRAWN: Metformin monotherapy for type 2 diabetes mellitus.
    Saenz A; Fernandez-Esteban I; Mataix A; Ausejo Segura M; Roqué i Figuls M; Moher D
    Cochrane Database Syst Rev; 2015 Sep; (9):CD002966. PubMed ID: 26421423
    [No Abstract]   [Full Text] [Related]  

  • 32. RCPE UK consensus statement on diabetes.
    Anderson A; Boyd K; Christie B; Claridge C; Currie P; Doherty T; Dorward D; Elder A; Hadley-Brown M; Hughes D; Jackson M; Jung R; Marshall S; MacKinnon M; Pollock A; Ritchie L
    J R Coll Physicians Edinb; 2010 Jun; 40(2):130-1. PubMed ID: 21125057
    [No Abstract]   [Full Text] [Related]  

  • 33. Metformin use and mortality among patients with diabetes and atherothrombosis.
    Roussel R; Travert F; Pasquet B; Wilson PW; Smith SC; Goto S; Ravaud P; Marre M; Porath A; Bhatt DL; Steg PG;
    Arch Intern Med; 2010 Nov; 170(21):1892-9. PubMed ID: 21098347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Addition of incretin therapy to metformin in type 2 diabetes.
    Scheen AJ; Radermecker RP
    Lancet; 2010 Apr; 375(9724):1410-2. PubMed ID: 20417840
    [No Abstract]   [Full Text] [Related]  

  • 35. [The UKPDS after one year. Diabetological realities and desiderata. United Kingdom Prospective Diabetes Study].
    Mehnert H
    Dtsch Med Wochenschr; 1999 Sep; 124(36):1021. PubMed ID: 10506838
    [No Abstract]   [Full Text] [Related]  

  • 36. What comes after metformin for type 2 diabetes.
    Med Lett Drugs Ther; 2012 Jul; 54(1395):58-9. PubMed ID: 22825689
    [No Abstract]   [Full Text] [Related]  

  • 37. Metformin: 50 years old, fit as a fiddle, and indispensable for its pivotal role in type 2 diabetes management.
    Halimi S
    Diabetes Metab; 2006 Dec; 32(6):555-6. PubMed ID: 17296508
    [No Abstract]   [Full Text] [Related]  

  • 38. Metformin in the management of type 2 diabetes.
    Howlett HC
    Diabet Med; 1989 Mar; 6(2):179-80. PubMed ID: 2522868
    [No Abstract]   [Full Text] [Related]  

  • 39. Seeing what you want to see in randomised controlled trials: versions and perversions of UKPDS data. United Kingdom prospective diabetes study.
    McCormack J; Greenhalgh T
    BMJ; 2000 Jun; 320(7251):1720-3. PubMed ID: 10864554
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus.
    Kim HJ; Kang ES; Kim DJ; Kim SH; Ahn CW; Cha BS; Nam M; Chung CH; Lee KW; Nam CM; Lee HC
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):282-9. PubMed ID: 17224000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.